A major regulatory milestone just hit the US stock market. The SEC greenlit fresh expiration cycles for Magnificent Seven stocks, signaling a broader push toward daily settlement options on individual equities. This move essentially dismantles barriers to more frequent trading cycles—think what daily options could mean for active traders and hedging strategies. The approval reflects growing appetite among market participants for tighter intraday risk management. Whether this accelerates adoption of single-stock options or reshapes typical trading patterns remains to be seen, but one thing's clear: the derivatives landscape keeps getting more sophisticated.